compound 19（Beijing Institute of Pharmacology and Toxicology）

N/A

Report date: 2022/10/20 14:49:47
NME

Base Information

Drug Namecompound 19（Beijing Institute of Pharmacology and Toxicology）
Drug Alias Name化合物19（北京药理毒理研究所）
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCapsid protein modulators
TargetsCapsid protein
Therapy Area/IndicationsRespiratory Tract Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Institute of Pharmacology and Toxicology
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Institute of Pharmacology and Toxicology
Inactive CompaniesN/A
Active IndicationsRespiratory Tract Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A